Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA SUVEN LIFE SCIENCES NATCO PHARMA/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 13.3 -20.5 - View Chart
P/BV x 3.5 5.8 60.4% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 NATCO PHARMA   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
SUVEN LIFE SCIENCES
Mar-23
NATCO PHARMA/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs84794 903.1%   
Low Rs50245 1,115.3%   
Sales per share (Unadj.) Rs148.40.6 23,895.8%  
Earnings per share (Unadj.) Rs39.2-5.4 -722.8%  
Cash flow per share (Unadj.) Rs48.2-5.1 -940.4%  
Dividends per share (Unadj.) Rs5.500-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs267.117.2 1,551.9%  
Shares outstanding (eoy) m182.47218.07 83.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.5111.8 4.1%   
Avg P/E ratio x17.2-12.8 -134.5%  
P/CF ratio (eoy) x14.0-13.5 -103.4%  
Price / Book Value ratio x2.54.0 62.6%  
Dividend payout %14.00-   
Avg Mkt Cap Rs m123,04915,131 813.2%   
No. of employees `000NANA-   
Total wages/salary Rs m4,867186 2,613.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,071135 19,994.8%  
Other income Rs m1,28584 1,520.9%   
Total revenues Rs m28,356220 12,896.1%   
Gross profit Rs m9,117-1,196 -762.1%  
Depreciation Rs m1,63865 2,503.4%   
Interest Rs m1455 2,695.2%   
Profit before tax Rs m8,619-1,183 -728.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4660-   
Profit after tax Rs m7,153-1,183 -604.8%  
Gross profit margin %33.7-883.6 -3.8%  
Effective tax rate %17.00-   
Net profit margin %26.4-873.5 -3.0%  
BALANCE SHEET DATA
Current assets Rs m30,0033,455 868.4%   
Current liabilities Rs m6,8311,050 650.4%   
Net working cap to sales %85.61,776.0 4.8%  
Current ratio x4.43.3 133.5%  
Inventory Days Days633,948 1.6%  
Debtors Days Days115218 53.0%  
Net fixed assets Rs m26,5711,373 1,934.9%   
Share capital Rs m365218 167.4%   
"Free" reserves Rs m48,3733,535 1,368.4%   
Net worth Rs m48,7383,753 1,298.6%   
Long term debt Rs m00-   
Total assets Rs m56,5744,828 1,171.8%  
Interest coverage x60.4-218.8 -27.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50 1,706.4%   
Return on assets %12.9-24.4 -52.9%  
Return on equity %14.7-31.5 -46.6%  
Return on capital %18.0-31.4 -57.3%  
Exports to sales %040.4 0.0%   
Imports to sales %10.2839.8 1.2%   
Exports (fob) Rs mNA55 0.0%   
Imports (cif) Rs m2,7721,137 243.8%   
Fx inflow Rs m17,25655 31,517.8%   
Fx outflow Rs m2,7721,137 243.8%   
Net fx Rs m14,484-1,082 -1,338.3%   
CASH FLOW
From Operations Rs m8,491-1,031 -823.2%  
From Investments Rs m-4,771-2,606 183.0%  
From Financial Activity Rs m-3,6303,955 -91.8%  
Net Cashflow Rs m208317 65.5%  

Share Holding

Indian Promoters % 49.7 69.6 71.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.0 0.6 4,540.0%  
FIIs % 13.7 0.5 2,540.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 50.3 30.4 165.3%  
Shareholders   207,571 74,003 280.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Natco Pharma vs Suven Life Sciences

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Natco Pharma vs Suven Life Sciences Share Price Performance

Period Natco Pharma Suven Life Sciences S&P BSE HEALTHCARE
1-Day -2.11% 0.30% 1.18%
1-Month -3.19% -2.06% -0.75%
1-Year 72.80% 114.92% 61.82%
3-Year CAGR 4.96% 14.94% 18.16%
5-Year CAGR 10.96% -16.22% 19.79%

* Compound Annual Growth Rate

Here are more details on the Natco Pharma share price and the Suven Life Sciences share price.

Moving on to shareholding structures...

The promoters of Natco Pharma hold a 49.7% stake in the company. In case of Suven Life Sciences the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Natco Pharma and the shareholding pattern of Suven Life Sciences.

Finally, a word on dividends...

In the most recent financial year, Natco Pharma paid a dividend of Rs 5.5 per share. This amounted to a Dividend Payout ratio of 14.0%.

Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Natco Pharma, and the dividend history of Suven Life Sciences.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.